Beleave Inc. Stock price Canadian Securities Exchange
Equities
BE
CA0775611084
Pharmaceuticals
Sales 2018 | - | Sales 2019 | 2.37 3.23 | Capitalization | 30.37M 41.28M |
---|---|---|---|---|---|
Net income 2018 | -12M -16.31M | Net income 2019 | -33M -44.85M | EV / Sales 2018 | - |
Net cash position 2018 | 5.2M 7.07M | Net Debt 2019 | 10.32M 14.02M | EV / Sales 2019 | 17,137,012 x |
P/E ratio 2018 |
-4.72
x | P/E ratio 2019 |
-0.76
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 98.39% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-05-25 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-14 |
Kevin Keagan
BRD | Director/Board Member | - | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-14 |
Founder | - | 00-05-25 | |
Kevin Keagan
BRD | Director/Board Member | - | 18-10-23 |
1st Jan change | Capi. | |
---|---|---|
+22.71% | 5.39B | |
-12.40% | 4.67B | |
-5.99% | 3.29B | |
-17.15% | 2.6B | |
-3.06% | 2.52B | |
-6.78% | 1.7B | |
-8.49% | 1.61B | |
+22.27% | 1.63B | |
-5.38% | 1.56B |